Real-World Evidence

Strategic OS for Pharmaceutical Market Access

Model treatment failure economics, design patient assistance programs, and generate global value dossiers. Built for pharmaceutical market access teams negotiating with payers across India, Singapore, and UAE.

<0s
Full drug economic analysis with AI
0
Markets -- India, Singapore, UAE
Auto
Global Value Dossier generation
Live
Regulatory data from government registries

What OncAccess Does

Six capabilities that change how market access teams prepare for payer negotiations.

LE

Liability Engine

Model the economic impact of treatment failure vs drug cost. Calculate per-patient liability across payer segments, factoring in regional pricing, dosing protocols, and disease progression. The numbers that change payer conversations.

PP

Dynamic Pricing Engine

Tiered pricing resolution: dosing metadata, indication-class defaults, and regional price benchmarks. Covers NPPA ceiling prices, international reference pricing, and payer-segment-specific economics.

GV

Global Value Dossier

7-section GVD auto-generated from live data. Clinical profile, economic analysis, competitive landscape, payer environment, budget impact, treatment pathway, and strategic recommendations. PDF-ready for payer submission.

PA

PAP Design Engine

Model patient assistance programs against real drug economics. Free cycles, co-pay caps, income-tiered access -- evaluate each scheme's impact on patient reach vs margin. Data-driven compassionate access.

CB

Competitive Benchmarking

Head-to-head drug comparison across clinical efficacy, pricing, and market position. TPP benchmarker for target product profiles. Understand exactly where your drug sits relative to every competitor in every market.

TI

Threat Intelligence

Real-time news and regulatory monitoring via AI-powered web search. Competitor launches, price changes, regulatory approvals, patent events -- surfaced automatically. Know before your competitor announces.

Data Foundation

Four data layers, continuously updated. No stale spreadsheets. No manual research.

CL

Clinical Data Layer

Comprehensive structured clinical profiles

Mechanism of action, indication mapping, dosing protocols, response rates, adverse event profiles, biomarker requirements. Sourced from regulatory filings and clinical registries, validated by AI cross-verification.

Drug LibraryMulti-IndicationDosing ProtocolsAI-Verified
PR

Pricing Intelligence

Regional pricing across 3 markets

MRP, institution pricing, tender rates, NPPA ceiling prices, international reference prices. Updated via live regulatory queries to CDSCO (India), HSA (Singapore), and EDE (UAE). Continuously updated pricing.

NPPA ValidatedCDSCO LiveHSA LiveEDE Live
HE

HEOR Economics

Health economics and outcomes research data

Per-market logistics costs, cold chain requirements, administration fees, monitoring costs, adverse event management costs. Tiered retrieval: AI-powered web research with verified constants fallback.

Cost-of-IllnessBudget ImpactLogisticsCold Chain
RG

Regulatory Intelligence

Live government registry queries

Direct approval status queries to government drug registries -- CDSCO for India, HSA for Singapore, EDE for UAE. No intermediary databases. 24-hour cache with automatic refresh. Continuously refreshed availability data.

CDSCO IndiaHSA SingaporeEDE UAE24h Refresh

AI-Powered Intelligence

Three tiers of AI -- from real-time search to deep multi-step research. Every response cited, cached, and cost-tracked.

GS

Gemini Search

Real-time web intelligence with citations

AI-powered web search grounded in Google Search. Drug profiles, competitor news, regulatory updates, and clinical evidence -- with source citations. 8-hour response cache for cost efficiency.

DR

Deep Research

Comprehensive multi-step synthesis

Gemini Deep Research for complex strategic questions. Multi-source synthesis over 10-15 minutes. Used for initial drug profiling and strategic briefing generation. Admin-controlled with cost tracking.

QA

Data Quality Automation

Comprehensive automated test suites

Builder Layer with 6 defense phases: Spec Engine, QA Gate, Sanitizer, Anomaly Detection, Cross-Verification, and Provenance tracking. Contract tests, data quality tests, and E2E tests. Monthly automated QA runs.

Three Markets. One Platform.

Regional pricing, regulatory frameworks, payer landscapes, and epidemiology -- pre-configured per market.

IN

India

CDSCO, NPPA ceiling prices, PMJAY

CDSCO RegistryNPPA PricesPayer SegmentsEpidemiology
SG

Singapore

HSA, Medifund, drug subsidy list

HSA RegistryDrug SubsidyMedifundPrivate Payers
AE

UAE

EDE, MOH formulary, insurance tiers

EDE RegistryMOH FormularyInsurance TiersDHA

How It Works

Search a drug. Get a complete economic profile. Generate a payer-ready dossier.

01

Search & Profile

Type a drug name. OncAccess pulls clinical data, pricing across markets, regulatory status, and competitive landscape. AI fills gaps from live web sources with citations.

02

Analyze & Model

Run the liability engine against payer segments. Model PAP scenarios. Compare competitors head-to-head. See exactly where your drug wins and where it doesn't.

03

Generate & Present

Auto-generate a 7-section Global Value Dossier, strategic briefing, or competitive intelligence report. PDF-ready. Data-stamped. Payer-submission grade.

See OncAccess in Action.

Live drug analysis, real pricing data, auto-generated dossier. 25 minutes.